{"id":"placebo-of-spm-962","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"Placebos are designed to appear identical to the active drug being tested but contain no active ingredients. They help researchers determine the true effect of the active drug by comparing outcomes against a baseline.","oneSentence":"Placebos do not have an active pharmacological mechanism; they are used as controls in clinical trials.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:39.021Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT00244387","phase":"PHASE3","title":"Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-03","conditions":"Parkinson Disease, Idiopathic","enrollment":506},{"nctId":"NCT01084551","phase":"PHASE3","title":"Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Co., Ltd.","startDate":"2010-02","conditions":"Idiopathic Restless Legs Syndrome","enrollment":284},{"nctId":"NCT01628926","phase":"PHASE3","title":"A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Co., Ltd.","startDate":"2009-06","conditions":"Parkinson's Disease","enrollment":420},{"nctId":"NCT00537485","phase":"PHASE2, PHASE3","title":"A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Co., Ltd.","startDate":"2007-09","conditions":"Early Parkinson's Disease","enrollment":180},{"nctId":"NCT01628848","phase":"PHASE2","title":"A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Co., Ltd.","startDate":"2006-08","conditions":"Parkinson's Disease","enrollment":174}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo of SPM 962","genericName":"Placebo of SPM 962","companyName":"Otsuka Pharmaceutical Co., Ltd.","companyId":"otsuka","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}